Role of Nitroglycerin administration through inhalation route as Nitric oxide donor in decreasing pulmonary hypertension as consequence of non-cyanotic congenital heart defects in - Egyptian Knowledge Bank

110991

Role of Nitroglycerin administration through inhalation route as Nitric oxide donor in decreasing pulmonary hypertension as consequence of non-cyanotic congenital heart defects in

Article

Last updated: 04 Jan 2025

Overview Similar Items

Article

Inhalational versus intravenous magnesium sulfate in management of pulmonary hypertension in neonates

Thesis

Role of sildenafil (viagra) in perioperative management of pulmonary hypertension in pediatric patients with congenital heart disease

Article

The Rule of Inhaled Salbutamol on The Outcome of Transient Tachypnea of Newborn

Article

Inhaled Salbutamol for the Treatment of Transient Tachypnea of the Newborn

Thesis

Comparative study of the effect of nitroglycerin, isoflurane or sevoflurane on tissue perfusion in pediatric cardiac surgery

Article

Role of selective pulmonary vasodilators in management of hypertensive ventricular septal defect in pediatrics

Article

Endothelin-1 in Pulmonary Artery Hypertension Secondary to Congenital Heart Disease

Article

Effects of phentolamine infusion during normoxic cardiopulmonary bypass on the outcome of cardiac surgery in children with cyanotic heart disease

Article

Comparison of the Effectiveness of Bosentan and Sildenafil in the Management of Persistent Pulmonary Arterial Hypertension in Neonates

Thesis

Nitric oxide in anaesthetic practice